Gragoudas E S, Seddon J M, Egan K M, Glynn R J, Goitein M, Munzenrider J, Verhey L, Urie M, Koehler A
Retina Service, Massachusetts Eye and Ear Infirmary, Boston 02114.
Ophthalmology. 1988 Jul;95(7):992-9. doi: 10.1016/s0161-6420(88)33091-5.
The incidence of metastasis and prognostic factors for metastasis in 780 consecutive patients with uveal melanomas treated with proton beam irradiation were evaluated. Metastasis developed in 64 patients (8%). The median time from treatment to the diagnosis of metastasis was 2.1 years (range, 3 months to 7.3 years). The liver was primarily involved in 58 (90%) patients. The 5-year cumulative probability of metastasis developing was 20%. Prognostic factors for metastasis developing were quite comparable to those found for patients treated by enucleation and included largest tumor diameter, involvement of the ciliary body, older age, and extrascleral extension. Surgical localization, tumor height, and elevated liver enzymes before treatment were not important factors in the development of metastasis.
对780例接受质子束照射治疗的脉络膜黑色素瘤患者的转移发生率及转移的预后因素进行了评估。64例患者(8%)发生转移。从治疗到转移诊断的中位时间为2.1年(范围3个月至7.3年)。58例(90%)患者主要累及肝脏。发生转移的5年累积概率为20%。转移发生的预后因素与眼球摘除术治疗的患者相当,包括最大肿瘤直径、睫状体受累、年龄较大和巩膜外扩展。手术定位、肿瘤高度和治疗前肝酶升高不是转移发生的重要因素。